4.7 Article

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

CXCL12-γ in primary tumors drives breast cancer metastasis

P. Ray et al.

ONCOGENE (2015)

Review Biochemistry & Molecular Biology

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Mark D. Turner et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)

Article Medicine, Research & Experimental

Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients

ChunHua Xu et al.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2014)

Review Respiratory System

Malignant Pleural Effusion: Medical Approaches for Diagnosis and Management

Hae-Seong Nam

TUBERCULOSIS AND RESPIRATORY DISEASES (2014)

Article Oncology

Cancer statistics, 2013

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

Review Respiratory System

Malignant Pleural Effusions A Review

Justin M. Thomas et al.

CLINICS IN CHEST MEDICINE (2013)

Article Respiratory System

Survival of lung adenocarcinoma patients with malignant pleural effusion

Shang-Gin Wu et al.

EUROPEAN RESPIRATORY JOURNAL (2013)

Article Multidisciplinary Sciences

Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion

Antonia Marazioti et al.

PLOS ONE (2013)

Article Oncology

Diagnostic Value of Interleukin 21 and Carcinoembryonic Antigen Levels in Malignant Pleural Effusions

Hansvin Bunjhoo et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)

Article Medicine, General & Internal

Recent Advances in the Diagnosis and Management of Malignant Pleural Effusions

John E. Heffner et al.

MAYO CLINIC PROCEEDINGS (2012)

Article Critical Care Medicine

Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Tzu-Hua Chang et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Review Health Care Sciences & Services

An Update in the Management of Malignant Pleural Effusion

D. K. Muduly et al.

INDIAN JOURNAL OF PALLIATIVE CARE (2011)

Article Biochemistry & Molecular Biology

Role of VEGF-stromal cell-derived factor-1α/CXCL12 axis in pleural effusion of lung cancer

Foteini Economidou et al.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2010)

Review Biochemistry & Molecular Biology

Chemokines and chemokine receptors: new insights into cancer-related inflammation

Gwendal Lazennec et al.

TRENDS IN MOLECULAR MEDICINE (2010)

Article Respiratory System

Animal models of malignant pleural effusion

Georgios T. Stathopoulos et al.

CURRENT OPINION IN PULMONARY MEDICINE (2009)

Article Biochemistry & Molecular Biology

Mutation of epidermal growth factor receptor is associated with MIG6 expression

Takeshi Nagashima et al.

FEBS JOURNAL (2009)

Editorial Material Medicine, General & Internal

Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer.

Adi F. Gazdar

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Critical Care Medicine

Zoledronic acid is effective against experimental malignant pleural effusion

Georgios T. Stathopoulos et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Medicine, General & Internal

Prognostic significance of pleural fluid data in patients with malignant effusion

Silvia Bielsa et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2008)

Article Oncology

A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion

Georgios T. Stathopoulos et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Review Cell Biology

Chemokines, chemokine receptors, and cancer metastasis

Takashi Kakinuma et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2006)

Article Medicine, General & Internal

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

H Greulich et al.

PLOS MEDICINE (2005)

Article Multidisciplinary Sciences

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

R Sordella et al.

SCIENCE (2004)

Article Critical Care Medicine

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

RJ Phillips et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)